GlassScriptPhysician profile
Jihoon Choi
NPI 1194285270
$1,649.07
in general payments reported to CMS, 2019-2025
10 companies · $864 in 2025
The $864 reported for 2025 was more than what 86% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $372 · 2024: $412 · 2025: $864.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,465 · Education: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,465.09 |
| Education | $183.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $333.98 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $250.00 | 2023-2024 | Tagrisso |
| Regeneron Healthcare Solutions, INC. | $241.86 | 2023-2025 | Libtayo |
| Amgen INC. | $125.00 | 2025 | Lumakras |
| Pfizer INC. | $125.00 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $124.39 | 2025 | Opdivo |
| Janssen Biotech, INC. | $122.43 | 2025 | Carvykti, Rybrevant |
| Alexion Pharmaceuticals, INC. | $122.43 | 2023 | |
| Kite Pharma, INC. | $103.21 | 2024 | Yescarta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.77 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jihoon Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.